Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors

被引:20
作者
Wheatley, M. [1 ]
Simms, J. [1 ]
Hawtin, S. R. [1 ]
Wesley, V. J. [1 ]
Wootten, D. [1 ]
Conner, M. [1 ]
Lawson, Z. [1 ]
Conner, A. C. [1 ]
Baker, A. [1 ]
Cashmore, Y. [1 ]
Kendrick, R. [1 ]
Parslow, R. A. [1 ]
机构
[1] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
基金
英国惠康基金;
关键词
agonist; G-protein-coupled receptor (GPCR); peptide hormone; receptor activation; vasopressin;
D O I
10.1042/BST0350717
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GPCRs (G-protein-coupled receptors) are a large family of structurally related proteins which mediate their effects by coupling to G-proteins. The V1aR (V-1a vasopressin receptor) is a member of a family of related GPCRs that are activated by vasopressin {AVP ([Arg(8)]vasopressin), OT (oxytocin) and related pepticles. These receptors are members of a subfamily of Family A GPCRs called the neurohypophysial peptide hormone receptor family. GPCRs exhibit a conserved tertiary structure comprising a bundle of seven TM (transmembrane) helices linked by alternating ECLs (extracellular loops) and 1CLs (intracellular loops). The cluster of TM helices is functionally important for ligand binding, and, furthermore, activation of GFCRs involves movement of these TM helices. Consequently, it might be assumed that the extracellular face of GPCRs is composed of peptide linkers that merely connect important TM helices. However, using a systematic mutagenesis approach and focusing on the N-terminus and the second ECL of the V1aR, we have established that these extracellular domains fulfil a range of important roles with respect to GPCR signalling, including agonist binding, ligand selectivity and receptor activation.
引用
收藏
页码:717 / 720
页数:4
相关论文
共 28 条
[1]  
Acher R, 1995, ADV EXP MED BIOL, V395, P615
[2]  
Ballasteros J. A., 1995, Methods in neurosciences, V25, P366
[3]   Structural bases of vasopressin/oxytocin receptor function [J].
Barberis, C ;
Mouillac, B ;
Durroux, T .
JOURNAL OF ENDOCRINOLOGY, 1998, 156 (02) :223-229
[4]   AN EXTRACELLULAR CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS MUTATION OF THE VASOPRESSIN RECEPTOR REDUCES CELL-SURFACE EXPRESSION, AFFINITY FOR LIGAND, AND COUPLING TO THE G(S)/ADENYLYL CYCLASE SYSTEM [J].
BIRNBAUMER, M ;
GILBERT, S ;
ROSENTHAL, W .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (07) :886-894
[5]  
CONNER M, 2007, J BIOL CHEM
[6]   MUTATIONAL ANALYSIS OF NEUROKININ RECEPTOR FUNCTION [J].
FONG, TM ;
HUANG, RRC ;
YU, H ;
SWAIN, CJ ;
UNDERWOOD, D ;
CASCIERI, MA ;
STRADER, CD .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (07) :860-865
[7]   The N-terminal juxtamembrane segment of the V1a vasopressin receptor provides two independent epitopes required for high-affinity agonist binding and signaling [J].
Hawtin, SR ;
Wesley, VJ ;
Simms, J ;
Argent, CCH ;
Latif, K ;
Wheatley, M .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (11) :2871-2881
[8]   A single residue (Arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists [J].
Hawtin, SR ;
Wesley, VJ ;
Parslow, RA ;
Simms, J ;
Miles, A ;
McEwan, K ;
Wheatley, M .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (03) :600-609
[9]   Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes [J].
Hawtin, SR ;
Howard, HC ;
Wheatley, M .
BIOCHEMICAL JOURNAL, 2001, 354 :465-472
[10]   Identification of the glycosylation sites utilized on the V1a vasopressin receptor and assessment of their role in receptor signalling and expression [J].
Hawtin, SR ;
Davies, ARL ;
Matthews, G ;
Wheatley, M .
BIOCHEMICAL JOURNAL, 2001, 357 (01) :73-81